mannose has been researched along with aluminum sulfate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goyal, AK; Khatri, K; Mehta, A; Mishra, N; Paliwal, R; Paliwal, S; Tiwari, S; Vaidya, B; Vyas, SP | 1 |
| Babayeva, M; Fomin, G; Petrovsky, N; Renu, S; Renukaradhya, GJ; Solomadin, M; Tabynov, K; Turebekov, N; Yadagiri, G; Yerubayev, T | 1 |
2 other study(ies) available for mannose and aluminum sulfate
| Article | Year |
|---|---|
Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery.
Topics: Adjuvants, Immunologic; Adsorption; Alum Compounds; Animals; Antibody Formation; Drug Carriers; Durapatite; Female; Immunoglobulin G; Malaria Vaccines; Mannose; Merozoite Surface Protein 1; Mice; Mice, Inbred BALB C; Nanoparticles; Plasmodium; Th1 Cells; Th2 Cells | 2009 |
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters.
Topics: Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Antibodies, Neutralizing; Antibodies, Viral; Chitosan; COVID-19; COVID-19 Vaccines; Cricetinae; Mannose; Mesocricetus; Mice; Mice, Inbred BALB C; Nanoparticles; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccines | 2023 |